CL2013003671A1 - Composition and pharmaceutical combination comprising ketorolac and meloxicam; process to prepare the composition; Use in the treatment of inflammation and pain. - Google Patents

Composition and pharmaceutical combination comprising ketorolac and meloxicam; process to prepare the composition; Use in the treatment of inflammation and pain.

Info

Publication number
CL2013003671A1
CL2013003671A1 CL2013003671A CL2013003671A CL2013003671A1 CL 2013003671 A1 CL2013003671 A1 CL 2013003671A1 CL 2013003671 A CL2013003671 A CL 2013003671A CL 2013003671 A CL2013003671 A CL 2013003671A CL 2013003671 A1 CL2013003671 A1 CL 2013003671A1
Authority
CL
Chile
Prior art keywords
composition
meloxicam
ketorolac
inflammation
pain
Prior art date
Application number
CL2013003671A
Other languages
Spanish (es)
Inventor
Paniagua Maria Angelica Arzola
Pelaez Juan Pablo Senosiain
Salgado Lopez Enrique Raul Garcia
Original Assignee
Laboratorios Senosiain S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Senosiain S A De C V filed Critical Laboratorios Senosiain S A De C V
Publication of CL2013003671A1 publication Critical patent/CL2013003671A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una combinación y composición farmacéutica y particularmente a una combinación de un analgésico y un antiinflamatorio seleccionado de ketorolaco y meloxicam, y vehículos o excipientes farmacéuticamente aceptables. También se refiere a un proceso de fabricación de una composición farmacéutica y al uso de dicha composición para elaborar un medicamento útil para tratar los padecimientos de dolor e inflamación.The present invention relates to a combination and pharmaceutical composition and particularly to a combination of an analgesic and an anti-inflammatory selected from ketorolac and meloxicam, and pharmaceutically acceptable carriers or excipients. It also refers to a manufacturing process of a pharmaceutical composition and the use of said composition to make a useful medicine to treat pain and inflammation.

CL2013003671A 2011-06-22 2013-12-20 Composition and pharmaceutical combination comprising ketorolac and meloxicam; process to prepare the composition; Use in the treatment of inflammation and pain. CL2013003671A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2011006758A MX357376B (en) 2011-06-22 2011-06-22 Pharmaceutical composition for use against inflammation and pain.

Publications (1)

Publication Number Publication Date
CL2013003671A1 true CL2013003671A1 (en) 2014-07-11

Family

ID=47422093

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013003671A CL2013003671A1 (en) 2011-06-22 2013-12-20 Composition and pharmaceutical combination comprising ketorolac and meloxicam; process to prepare the composition; Use in the treatment of inflammation and pain.

Country Status (13)

Country Link
AR (1) AR086733A1 (en)
BR (1) BR112013033007A2 (en)
CL (1) CL2013003671A1 (en)
CO (1) CO6831987A2 (en)
CR (1) CR20130687A (en)
DO (1) DOP2013000309A (en)
ES (1) ES2441917B1 (en)
GT (1) GT201300318A (en)
MX (1) MX357376B (en)
NI (1) NI201300142A (en)
PE (1) PE20141530A1 (en)
RU (1) RU2604149C2 (en)
WO (1) WO2012176155A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014193210A1 (en) * 2013-05-27 2014-12-04 Farmacêuticos Rayere, S.A. Synergistic pharmaceutical composition of two analgesics having a distinct pharmacokinetic profile

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (en) * 1984-10-22 1988-11-16 Chiesi Farma Spa AQUEOUS PHARMACEUTICAL FORMULATIONS OF PIROXICAM MONOHYDRATE
US5091182A (en) * 1990-07-23 1992-02-25 Syntex (U.S.A.) Inc. Dispensing units for ketorolac topical gel formlations
US5436241A (en) * 1994-01-14 1995-07-25 Bristol-Myers Squibb Company Topical anti-inflammatory compositions containing piroxicam
MXPA02010828A (en) * 2002-11-04 2004-07-16 Leopoldo Espinosa Abdala Pharmaceutical composition in capsules comprising a non-steroidal anti-inflammatory and an opiate analgesic for handling pain.
RU2237470C1 (en) * 2003-01-27 2004-10-10 Купсин Евгений Вениаминович Combined preparation for removing symptoms of catarrhal diseases and grippe (variants)
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
MXPA04009698A (en) * 2004-10-04 2006-04-05 Maria Elena Garcia Armenta Solid pharmaceutical formulations comprising diacereine and meloxicam.
WO2007148950A1 (en) * 2006-06-20 2007-12-27 Farmacéuticos Rayere, S.A. Synergistic pharmaceutical composition of ketorolac and lysine clonixinate
MX2007003948A (en) * 2007-04-02 2009-02-25 World Trade Imp Export Wtie Ag Pharmaceutical composition in the form of a sublingual tablet consisting of a non-steroidal anti-inflammatory agent and an opiate analgesic for pain management.
US20080026054A1 (en) * 2007-04-27 2008-01-31 Nectid Inc. Novel anelgesic combination

Also Published As

Publication number Publication date
ES2441917B1 (en) 2014-11-25
ES2441917R1 (en) 2014-02-19
CO6831987A2 (en) 2014-01-10
MX357376B (en) 2018-07-06
DOP2013000309A (en) 2014-04-15
GT201300318A (en) 2015-05-21
MX2011006758A (en) 2013-01-10
CR20130687A (en) 2014-02-21
PE20141530A1 (en) 2014-11-12
AR086733A1 (en) 2014-01-15
BR112013033007A2 (en) 2017-01-31
RU2013157013A (en) 2015-07-27
WO2012176155A1 (en) 2012-12-27
NI201300142A (en) 2015-02-25
ES2441917A2 (en) 2014-02-06
RU2604149C2 (en) 2016-12-10

Similar Documents

Publication Publication Date Title
SV2015005115A (en) DERIVATIVES OF PIRAZOLOPIRROLIDINE AND ITS USE IN THE TREATMENT OF DISEASES
CL2013000063A1 (en) A method of treating a subject comprising administering optionally deuterated n-ethyl-n-phenyl1,2-dihydroxy-4-hodroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, for the treatment of a disease autoimmune; a mixture thereof; Pharmaceutical composition and its preparation process.
CL2015001891A1 (en) Enclosed controlled dose dosage forms resistant to tampering; use to treat pain; and method of preparation. (divisional of the application n ° 2754-2014).
EA201591751A1 (en) TRIPEPTIDE EPOKEKETONE PROTEASE INHIBITORS
AR091876A1 (en) PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
SV2010003451A (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES
UY33183A (en) INHIBITING COMPOUNDS OF VIRUS FLAVIVIRIDAE, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT
BR112015009228A8 (en) STERILE LIQUID PHARMACEUTICAL FORMULATION AND STERILE LIQUID OPHTHALMIC INTRAOCULAR DOSAGE FOR INJECTION
CO6491060A2 (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITARY DISEASES
UY33277A (en) SPIRO-TETRACICLIC RING COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE
CL2014001016A1 (en) Condensed tricyclic compounds and their pharmaceutically acceptable salts; pharmaceutical composition that includes them; and its use in the treatment of a viral infection.
EA201491479A1 (en) DERIVATIVES OF LUPANOV TRITERPENOIDS AND THEIR PHARMACEUTICAL APPLICATIONS
AR096892A1 (en) A PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF MELANOMA
CL2010001406A1 (en) Ophthalmic pharmaceutical composition comprising povidone iodine, and a steroidal anti-inflammatory compound, a non-steroidal anti-inflammatory compound, an antibacterial, an anti-allergic or an anti-glaucoma compound; and method to preserve the composition.
EA201491039A1 (en) COMBINATION DIACEREIN AND NONSTEROIDAL ANTI-INFLAMMATORY MEDICINES
BR112015029894A2 (en) solid pharmaceutical dosage form
CY1123695T1 (en) PHARMACEUTICAL COMPOSITION WITH ANTI-INFLAMMATORY AGENTS AND PROCESS OF PREPARATION
SV2010003773A (en) 7-SULFANILMETIL-, 7-SULFINILMETIL- AND 7-SULFONILMETILINDOLES REPLACED AND THE USE OF THE SAME
EA201591603A1 (en) NEW THERAPEUTIC COMBINATIONS MYRTAZAPINE FOR APPLICATION IN PAIN DISEASES
CL2013003671A1 (en) Composition and pharmaceutical combination comprising ketorolac and meloxicam; process to prepare the composition; Use in the treatment of inflammation and pain.
ECSP088801A (en) PHARMACEUTICAL COMPOSITION INCLUDING THE COMBINATION OF A KETOROLACO SALT AND VITAMINS OF COMPLEX B FOR THE TREATMENT OF NEURALGIA
CL2016002655A1 (en) Pharmaceutical composition for the treatment of pain-related allopathies, using as active agent ketorolac tromethamine and tramadol hydrochloride
ES2422877B1 (en) COMBINATION AND COMPOSITION FOR OBESITY TREATMENT
ECSP13012765A (en) COMBINATION AND COMPOSITION FOR OBESITY TREATMENT
CO7170180A2 (en) Injectable pharmaceutical composition of dexketoprofen and tramadol